|
|
||||||||
J Thorac Cardiovasc Surg 2003;125:1350-1362
© 2003 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
From the Departments of Thoracic and Cardiovascular Surgerya and Biostatistics and Epidemiology,b The Cleveland Clinic Foundation, Cleveland, Ohio.
Received for publication May 10, 2002. Revisions requested July 18, 2002; revisions received Aug 21, 2002. Accepted for publication Aug 27, 2002. Address for reprints: Marc Gillinov, MD, The Cleveland Clinic Foundation, 9500 Euclid Ave/Desk F24, Cleveland, OH 44195 (E-mail: gillinom{at}ccf.org).
Objective: We sought to compare mitral valve repair and replacement as treatments for degenerative mitral valve disease with coexisting ischemic heart disease. Specifically, we sought to (1) identify differences between patients undergoing repair and replacement, (2) determine whether the choice of mitral valve procedure affected survival after adjusting for those differences, and (3) discover which patients were predicted to benefit from mitral valve repair and which from replacement.
Methods: From 1973 to 1999, 679 patients (mean age, 67 ± 9.1 years; 73% men) with degenerative mitral valve and ischemic heart diseases underwent combined coronary artery bypass grafting and either mitral valve repair (66%) or replacement (34%). Factors associated with repair and replacement were used for multivariable propensity matching. Risk factors for death were identified by means of multivariable, multiphase hazard-function analysis.
Results: Patients more likely to undergo repair had isolated posterior chordal rupture (P < .0001) or more recent date of operation (P < .0001); those more likely to undergo replacement were older (P = .0003) or had bileaflet prolapse (P < .0001). Unadjusted survival at 30 days and 1, 5, and 10 years was 97%, 92%, 79%, and 59% after repair and 94%, 88%, 70%, and 37% after replacement. After adjusting for comorbid factors, the extent and effect of ischemic heart disease, and propensity score, the survival benefit of repair became evident after 2 years (P = .01). Eighty-nine percent of patients were predicted to benefit from repair.
Conclusions: In patients with degenerative mitral valve and ischemic heart diseases, mitral valve repair confers a survival advantage over replacement that becomes evident about 2 years after the operation.
Related Article
J. Thorac. Cardiovasc. Surg. 125: 1197-1199.
This article has been cited by other articles:
![]() |
A. M. Gillinov, E. H. Blackstone, E. R. Nowicki, W. Slisatkorn, G. Al-Dossari, D. R. Johnston, K. M. George, P. L. Houghtaling, B. Griffin, J. F. Sabik III, et al. Valve repair versus valve replacement for degenerative mitral valve disease. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 885 - 893.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.M. Fedak, P. M. McCarthy, and R. O. Bonow Evolving Concepts and Technologies in Mitral Valve Repair Circulation, February 19, 2008; 117(7): 963 - 974. [Full Text] [PDF] |
||||
![]() |
J. Shuhaiber and R. J. Anderson Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 267 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Buckberg Editorial comment: Left ventricular reconstruction for dilated ischemic cardiomyopathy: biology, registry, randomization, and credibility Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 759 - 761. [Full Text] [PDF] |
||||
![]() |
S M Tuladhar and P P Punjabi Surgical reconstruction of the mitral valve Heart, October 1, 2006; 92(10): 1373 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF] |
||||
![]() |
G. D. Buckberg and the RESTORE Group Form versus disease: optimizing geometry during ventricular restoration Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S238 - S244. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Webb, J. Harnek, B. I. Munt, P. O. Kimblad, M. Chandavimol, C. R. Thompson, J. R. Mayo, and J. O. Solem Percutaneous Transvenous Mitral Annuloplasty: Initial Human Experience With Device Implantation in the Coronary Sinus Circulation, February 14, 2006; 113(6): 851 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aybek, P. Risteski, A. Miskovic, A. Simon, S. Dogan, U. Abdel-Rahman, and A. Moritz Seven years' experience with suture annuloplasty for mitral valve repair J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 99 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillinov, E. H. Blackstone, J. Rajeswaran, M. Mawad, P. M. McCarthy, J. F. Sabik III, T. Shiota, B. W. Lytle, and D. M. Cosgrove Ischemic Versus Degenerative Mitral Regurgitation: Does Etiology Affect Survival? Ann. Thorac. Surg., September 1, 2005; 80(3): 811 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Glower, R. H. Tuttle, L. K. Shaw, R. E. Orozco, and J. S. Rankin Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 860 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Langer, D. Aicher, A. Kissinger, O. Wendler, H. Lausberg, R. Fries, and H.-J. Schafers Aortic Valve Repair Using a Differentiated Surgical Strategy Circulation, September 14, 2004; 110(11_suppl_1): II-67 - II-73. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Adams and F. Filsoufi Another chapter in an enlarging book: Repair degenerative mitral valves J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1197 - 1199. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |